Antimicrobial resistance has become increasingly common among organisms associated with both communityacquired and healthcare-associated infections. 1,2 Antimicrobial use is a major factor associated with resistance. Furthermore, several studies have demonstrated that considerable amounts of antimicrobial use in hospitalized patients are excessive or inappropriate. 3, 4 The Centers for Disease Control and Prevention (CDC), the National Foundation for Infectious Diseases, the Society for Healthcare Epidemiology of America (SHEA), and the Infectious Diseases Society of America (IDSA) have individually or jointly published consensus statements calling for hospitals to monitor antimicrobial use and reduce inappropriate usage. 5, 6 Among the specific recommendations, a position paper developed by IDSA and SHEA stated that hospitals should "establish a system for monitoring bacterial resistance and antibiotic usage; establish practice guidelines and other institutional policies to control the use of antibiotics and respond to data from the monitoring system." 6 Many hospitals employ programs to improve antimicrobial use, which may include restrictions on specific agents, automatic stop orders, clinical practice guidelines (CPGs), and multidisciplinary teams. Evaluation of some programs has been done at single institutions, and recent reports have demonstrated a decrease in antimicrobial resistance in temporal association with implementation of some of these practices. [7] [8] [9] [10] In an effort to determine what type of antimicrobial-use programs are used at hospitals, a survey was conducted at all 47 US hospitals participating in phase 3 of Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE).
METHODS

Hospitals
ICARE hospitals are a subset of hospitals participating in the intensive care unit (ICU) component of the CDC's National Nosocomial Infections Surveillance (NNIS) System. 1 Hospital demographics (eg, bed size, teaching
Programs to Improve Antimicrobial Use
Information on antimicrobial-use programs was obtained by a survey in February 1998. Survey instructions asked that the ICARE primary contact (usually an infection control professional) distribute appropriate sections of the survey to pharmacy staff and that the person completing the forms include their name and telephone number in case clarification was needed. Therefore, surveys were completed by pharmacy staff, infection control staff, or a combination thereof. Ambiguous responses were clarified by follow-up telephone calls to the same staff initially completing the survey. Four aspects of programs were considered: specific policies to influence antimicrobial choice, CPGs, peer education, and the role of the clinical pharmacist. Specific policies included formular y status (whether the drug was approved for use within the institution), restriction (whether the drug required prior approval by designated authority), and automatic stop orders (whether the antimicrobial agent was discontinued after a set period of time unless reordered) for each of 28 select antimicrobials. CPGs were categorized into two groups: criteria-based guidelines (those describing appropriate vs inappropriate use for specific drugs or groups of drugs), and diagnosis-based guidelines (those describing treatment guidelines by syndrome or clinical condition). Responses were entered into Epi Info (version 4; CDC, Atlanta, GA) and analyzed using SAS (release 6.12; SAS Institute, Inc, Cary, NC). Potential factors associated with specific antimicrobial-control programs were evaluated using frequency distributions and chi-square analysis.
RESULTS
Hospital Description
All 47 hospitals returned the survey and had a median of 378 (range, 147-1,022) hospital beds and a median of 4 (range, 1-8) ICUs. Types of ICUs reported included 34 medical-surgical combined (24%), 25 medical (18%), 17 general surgical (12%), 17 hematology-oncology or bone marrow transplant (12%), 15 coronary care (11%), 12 cardiothoracic (9%), 8 neurosurgical (6%), 6 pediatric (4%), and 5 other (4%). Most hospitals (72%) reported affiliation with a teaching institution and were general service hospitals (89%), although there were 4 Veterans' Administration hospitals and 1 children's hospital. Responding hospitals were located throughout the United States.
Specific Policies
All hospitals reported using at least one of the practices listed in the survey. All used a formulary, and 43 (91%) used it in conjunction with at least one of the other three antimicrobial-use policies evaluated: stop orders, restriction, and criteria-based CPGs. Hospitals listed a median of 20 (71%) of the 28 (range, 13-28) surveyed antimicrobials in their formulary. Four antimicrobials were listed on all hospital formularies: ampicillin, penicillin G, cefazolin, and vancomycin ( Figure) .
Nineteen hospitals (40%) reported restrictions on at least one antimicrobial (median, 7; range, 1-17; Table) . Hospitalwide restriction was reported most commonly for imipenem, ciprofloxacin, ceftazidime, and ticarcillinclavulanic acid (Figure) . All restrictions were hospitalwide, with six exceptions in which select drugs had restricted access outside of pediatrics (ticarcillin, cefoxitin, cefotaxime, ceftriaxone) or the ICU (cefoxitin, ciprofloxacin) only. Teaching hospitals were significantly more likely than other hospitals to restrict antimicrobials (odds ratio [OR], 12.0; 95% confidence interval [CI 95 ], 1.9-75.9).
Automatic stop orders were reported at 28 hospitals (60%) on a median of 20 (range, 2-28) antimicrobials (Table) . Only 4 (14%) of the 28 used the stop orders on nonformulary antimicrobials. Stop orders were most common for ampicillin, penicillin G, cefazolin, vancomycin, and trimethoprim-sulfamethoxazole.
Clinical Practice Guidelines
CPGs were reported at 33 hospitals (70% ; Table) . Of diagnosis-based guidelines, those for surgical prophylaxis and treatment of community-acquired pneumonia were the most common. The most common criteria-based guideline, reported at 29 hospitals (62%), was for vancomycin (Table) . Teaching hospitals were significantly more likely than other hospitals to have CPGs for treatment of communityacquired pneumonia (OR, 4.2; CI 95 , 1.03-17.4) or use of vancomycin (OR, 3.8; CI 95 , 1.03-14.3).
The method of dissemination of CPGs varied. Dissemination of diagnosis-based guidelines by newsletter or personal letter to doctors was each reported at 17 (52%) of the 33 hospitals with CPGs. Dissemination of criteriabased guidelines by personal letter to the doctor was reported at 20 (61%) hospitals, and dissemination by newsletter was reported at 24 (73%) hospitals. Other methods of dissemination reported included placement of a form in the patient's chart, lecture handouts, computer- April 2000 assisted prescribing, utilization of a pocket guide, and placement of guidelines at the nurses' station.
Peer Education and Pharmacy Interventions
At 33 hospitals (70%), infectious disease consults were used to influence initial antimicrobial choice, and 31 hospitals (66%) had a system for formal pharmacy consultation about initial antimicrobial choice (Table) . Only 4 hospitals (9%) used computer-assisted prescribing routinely to influence initial antimicrobial choice. However, fewer than one half (40%) reported a system to measure compliance with any of the above consultations. Of note, hospitals that routinely used either informal or formal pharmacy consultation for initial antimicrobial choice were less likely to have restriction policies (OR, 0.24; CI 95 , 0.07-0.88). However, a similar association was not found between hospitals reporting routine use of infectious disease consultation to influence initial antimicrobial selection and having restriction policies (OR, 0.87; CI 95 , 0.24-3.12). Thirty (64%) hospitals reported a system to measure physician compliance with pharmacy antimicrobial dosing recommendations, and 30 (64%) reported a system routinely to recommend changes in antimicrobial selection based on pathogen susceptibility data (Table) .
DISCUSSION
Our survey of 47 hospitals across the United States shows that all surveyed hospitals reported some sort of program to improve use of antimicrobials. However, the types of programs reported varied considerably, both by specific agents involved and mechanisms used, which supports previous findings. 10 According to the SHEA-IDSA position paper, controlling antimicrobial use is not enough to combat resistance. 6 Hospitals also must focus on appropriateness of use, and respond to data from a monitoring system. Of hospitals we surveyed, only 70% had CPGs that addressed such issues, and less than one half of the hospitals had a system to measure compliance with consultations on initial antimicrobial choice. Furthermore, despite recent evidence that selected restrictions decrease antimicrobial resistance, only 40% of hospitals restricted any antimicrobials. 7, 8 Therefore, it is evident that, in most hospitals surveyed, practices to improve antimicrobial use existed. However, these efforts should be considered a first step in approaching more comprehensive programs such as those described in the SHEA-IDSA position paper. One limitation of this study is that we have no information on enforcement of, or changes in, the reported practices. However, this survey provides an overview of some of the more commonly reported methods to improve antimicrobial use. Our data demonstrate the variety of programs currently used and may reflect the current lack of data demonstrating that any one program is more effective than others.
